SEC Filing Summary: Second Sight Medical Products, Inc.
Business Context and Reporting Period
This Form 8-K was filed on January 21, 2020, by Second Sight Medical Products, Inc. (trading symbol: EYES). The report addresses a regulatory compliance matter regarding the company's listing status on the Nasdaq Stock Market.
Key Financial Metrics
The filing text does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on stock price compliance.
Material Changes
The primary event reported is the restoration of compliance with Nasdaq Listing Rule 5550(a)(2). The company's common stock closing bid price remained at or above $1.00 per share for 10 consecutive business days (January 6 to January 17, 2020). This resolves a previous deficiency notification received in January 2019 regarding failure to maintain the minimum $1.00 bid price.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on operations, or discussion of new risks. The matter of non-compliance is now closed.
Investor Verification Checklist
- Verify the current trading status of Second Sight Medical Products, Inc. (EYES) on Nasdaq.
- Confirm the company's stock price performance relative to the $1.00 minimum bid requirement in subsequent periods.
- Review prior filings from January 2019 to understand the duration and context of the previous non-compliance notice.